Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Search results for: musculoskeletal

Giant Cell Arteritis

  |  

Giant cell arteritis (GCA)—a type of vasculitis—is a group of diseases whose typical feature is inflammation of blood vessels. The blood vessels most commonly involved are the arteries of the scalp and head (especially the arteries over the temples), which is why another term for GCA is “temporal arteritis.” GCA can overlap with another rheumatic disease called polymyalgia rheumatica, and symptoms of the two conditions can occur at the same time or separately. The causes of GCA and polymyalgia rheumatica are unknown.

In Memoriam: John Bland, MD

Paul Plotz, MD  |  

John Hardesty Bland, MD, professor of medicine emeritus at the University of Vermont College of Medicine in Burlington, died on March 15, 2007. He was midway through his 90th year, fulfilling the prescription of his last book, Live Long, Die Fast: Playing the Aging Game to Win, published when he was 80. A consummate rheumatologist and wonderful bedside doctor and teacher, Dr. Bland was also one of the genuine polymaths in the American medical world.

Increase NIH Funding, Participate in Advocates for Arthritis

  |  

The ACR consistently urges Congress to support issues relating to rheumatologists, rheumatology health professionals, and patients. The primary advocacy goals are: supporting of the “Arthritis Prevention, Control, and Cure Act of 2007” (H.R.1283/S.626) and the “Access to Medicare Imaging Act of 2007” (H.R.1293/S.1338), finding a permanent solution to the Medicare reimbursement issue, and increasing funding for the National Institutes of Health (NIH)—including the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the National Institute of Allergy and Infectious Diseases—and other agencies, such as the Centers for Disease Control and Prevention, the Agency for Healthcare Research and Quality, the Department of Veterans Affairs’ Medical and Prosthetic Research Program.

ARHP in 2008

Kimberly Kimpton, PT  |  

As I begin my presidency, let me thank you—the ARHP membership—for allowing me to steer this organization through the 2008 year. As a physical therapist in clinical practice for more than 25 years, I have experienced the challenges of treating people with arthritis and rheumatic diseases. For the past 13 years, I have served the ARHP in various capacities and, as my personal involvement in the ARHP has grown, my knowledge of this premier rheumatology organization has also expanded.